HeraMED (ASX:HMD) has signed a memorandum of understanding with Gold Coast Hospital and Health Service (GCHHS) to trial the HeraCARE platform for its Women Newborn and Children Services.
The trial will include up to 90 high-risk pregnancies for a period of six to nine months, with the goal of evaluating clinical usability, patient satisfaction, and economic analysis.
If the trial is successful, GCHHS intends to order additional licenses for the platform, which could potentially become its standard maternity care model.
GCHHS currently manages more than 5000 pregnancies each year.